Rodolphe is focusing on the characterization of CRISPR-Cas systems, and their applications in bacteria and beyond. Rodolphe spent 9 years in R&D and M&A at DuPont. For his CRISPR work, Rodolphe received several international awards, and has been elected into the National Academy of Sciences, the National Academy of Engineering and the National Academy of Inventors. He has been affiliated with multiple start-up companies and is a co-founder of Intellia Therapeutics, Locus Biosciences, TreeCo, CRISPR Biotechnologies, and Ancilia Biosciences.
Rodolphe Barrangou, PhD
T. R. Klaenhammer Distinguished Professor in Probiotics Research
North Carolina State University